Relation between infection and autoimmunity in mixed cryoglobulinemia

被引:71
作者
Ferri, C
Zignego, AL
机构
[1] Univ Pisa, Rheumatol Unit, Dipartimento Med Interna, I-56100 Pisa, Italy
[2] Univ Florence, Dipartimento Med Interna, I-50121 Florence, Italy
关键词
D O I
10.1097/00002281-200001000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mixed cryoglobulinemia (MC) is a systemic vasculitis of small to medium-sized vessels due to the vascular deposition of circulating immune-complexes (CIC) and complement. A leukocytoclastic vasculitis is the histologic hallmark of cutaneous manifestations of the disease, while a clonal B lymphocyte expansion in blood, bone marrow, liver, and spleen represents the underlying pathologic alteration responsible for the production of cryo-CIC and non-cryo CIC with rheumatoid factor activity. A causative role of hepatitis C virus (HCV) infection has been demonstrated in the large majority of MC patients. Hepatitis C virus is both a hepatotropic and a lymphotropic virus; due to this latter biological peculiarity, HCV may trigger a constellation of autoimmune-lymphoproliferative disorders, Besides MC, other important HCV-related diseases are porphyria cutanea tarda, autoimmune hepatitis, membranoproliferative glomerulonephritis,: and B cell neoplasias. Hepatitis C virus-related MC represents a link between autoimmune and lymphoproliferative disorders; moreover, MC is an important model to study the complex relation between infections and immune system alterations in humans. During the last years many other autoimmune manifestations have been correlated with HCV infection; namely, sicca syndrome, chronic polyarthritis, polydermatomyositis, fibromyalgia, autoimmune thyroiditis, lung fibrosis, and diabetes mellitus. It is often difficult to verify whether the above associations are coincidental or a pathogenetic link actually exists. At least for particular patients' subsets and in some geographic areas, a causative role of HCV seems to be likely. The geographically heterogeneous distribution of HCV-related autoimmune diseases suggests the contribution of important environmental and genetic factors in the pathogenesis of such conditions. In clinical practice, patients with recent-onset, atypical rheumatic and autoimmune disorders should be carefully investigated for possible HCV infection; this is particularly advisable for correct diagnosis and adequate therapeutic strategy. (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 74 条
[1]   HEPATITIS-C VIRUS-INFECTION IN TYPE-II MIXED CRYOGLOBULINEMIA [J].
ABEL, G ;
ZHANG, QX ;
AGNELLO, V .
ARTHRITIS AND RHEUMATISM, 1993, 36 (10) :1341-1349
[2]   Perspectives for a hepatitis C virus vaccine [J].
Abrignani, S ;
Rosa, D .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1998, 10 (2-3) :181-185
[3]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[4]   Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia [J].
Agnello, V ;
Abel, G .
ARTHRITIS AND RHEUMATISM, 1997, 40 (11) :2007-2015
[5]   Thyroid cancer in patients with hepatitis C infection [J].
Antonelli, A ;
Ferri, C ;
Fallahi, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1588-1588
[6]  
BOMBARDIERI S, 1979, Ricerca in Clinica e in Laboratorio, V9, P361
[7]  
BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3
[8]   Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients [J].
Buskila, D ;
Shnaider, A ;
Neumann, L ;
Lorber, M ;
Zilberman, D ;
Hilzenrat, N ;
Kuperman, OJ ;
Sikuler, E .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 28 (02) :107-113
[9]   Fibromyalgia in hepatitis C virus infection - Another infectious disease relationship [J].
Buskila, D ;
Shnaider, A ;
Neumann, L ;
Zilberman, D ;
Hilzenrat, N ;
Sikuler, E .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (21) :2497-2500
[10]  
Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO